We use strictly necessary cookies to make our site work. We would also like to set optional cookies (analytical, functional and YouTube) to enhance and improve our service. You can opt-out of these cookies. By clicking “Accept All Cookies” you can agree to the use of all cookies.

Cookies Statement and Privacy Statement


Supply of medicines

We are working with the Department of Health, the Health Products Regulatory Authority (HPRA) and industry to reduce and deal with any risk to the supply of medicines.

There is no need for patients, pharmacists or hospitals to order extra medicines. This could disrupt stocks and reduce the supply of medicines for other patients.

There are already extra stocks of medicines built into the supply chain. The Office of the Revenue Commissioners has made plans to help get essential medicines into the country. This and the extra stocks will help deal with any delays and shortages.

Supply of specific products

Medicines shortages are happening more often worldwide. This has nothing to do with Brexit.

In 2018, the HPRA launched the Medicine Shortages Framework. This is to manage and deal with shortages or potential shortages. This will reduce the effects on patients.

There are about 4,000 medicines marketed in Ireland. A number of them come from, or travel through, the UK.

Companies have been reviewing these arrangements to try and avoid delays in supply. They are also considering other supply routes, if needed.

We have not identified any major issues with the availability of specific products. We will be working with the HPRA to identify alternative products if specific issues are identified.

More information

Read about the GDPR requirements for HSE services for HSE staff on the Brexit GDPR page on the HSE intranet.

Email any HSE-related Brexit questions to brexit@hse.ie.